Back to trials
active not recruiting
Not Applicable

NCT03396640

Medial Unicondylar Knee Arthroplasty vs Total Knee Arthroplasty

Sponsored by University Hospital, Gentofte, Copenhagen

Summary

In treatment of isolated medial unicondylar osteoarthritis of the knee (MU-OA), it is possible to choose between surgery with a unicondylar knee arthroplasty (UKA), or a total knee arthroplasty (TKA). Supporters of TKA suggest that this treatment gives a more predictable and better result, whereas supporters of UKA suggest that it is unnecessary to remove decent and functional cartilage in other compartments, and also that generally the UKA gives better results under certain circumstances. If the UKA is worn out or loosens, revision surgery will be relatively easy, whereas revision-surgery after a TKA can be much more problematic. Also, it is of great interest to measure the direct costs of these treatments. Both general hospital costs, but also costs in societal in terms of sick-days, pain-killer expenditure, and physiotherapy. The aim of this study is to compare the results, in terms of 1) patient-reported outcomes, 2) clinical results including prosthetic survival and 3) costs.

Eligibility Criteria

Inclusion Criteria: Anteromedial OA of the knee as diagnosed on posteroanterior and lateral projections of the knee, and symptoms of sufficient severity to justify arthroplasty. Each patient can only participate with one knee, but may be eligible with both knees. Eligibility is independent of possible previous procedures to index or contralateral knee, and to age, sex, occupation and etiology of the anteromedial OA. Bone og Bone medially on pre-operative radiographs. Exclusion Criteria: 1. knee instability caused by either cruciate or collateral ligament insufficiency, 2. rheumatoid or other inflammatory arthropathy, 3) lateral patellar subluxation on skyline views with articular cartilage thinning of the patellofemoral joint. Specific exclusion criteria for study participation are: 1) age below 18 years of age, 2) limited possibilities of understanding and assessing study information (e.g. severe psychiatric or mental conditions and non-Danish speaking), 3) occupational or personal relation to surgeons responsible for treatment (e.g. employment in participating orthopedic departments).

Locations (11)

Bispebjerg Hospital

Copenhagen, Bispebjerg, Denmark

Randers Hospital

Randers, Central Jutland, Denmark

Silkeborg Hospital

Silkeborg, Central Jutland, Denmark

Gentofe Hospital

Copenhagen, Gentofte, Denmark

Aarhus Universitetshospital

Aarhus, Denmark

Aalborg Universitetshospital, Farsø

Farsø, Denmark

Andreas Kappel

Farsø, Denmark

Frederikshavn Sygehus

Frederikshavn, Denmark

Næstved Sygehus

Næstved, Denmark

Svendborg Sygehus

Svendborg, Denmark

Vejle Sygehus

Vejle, Denmark

Why you can trust this information
Registry sourcesclinicaltrials_gov
Source last updated10/23/2023
Clintriva indexed9/27/2026, 9:24:19 PM
Registry records1
Relationships needing review0

Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.

Interested in this trial?

Express your interest and we'll connect you with the trial team.

Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.

Quick Facts
Start DateAug 17, 2017
CompletionOct 16, 2041
Enrollment0/350
CountryDenmark

Conditions

Osteoarthritis, Knee
View on registry
Clintriva
GDPR Controls Mapped HIPAA Safeguards Mapped NHS DSP Controls Mapped SOC 2 Controls Mapped

© 2026 Clintriva. All rights reserved.